Pertussis (also known as whooping cough) continues to be a global health problem with an estimated 45 million cases annually and 300,00 deaths, which occur mostly in children. Despite high vaccine coverage, incidence has been increasing in several developed countries since the 1990s, due apparently to waning immunity in adolescents and young adults who were vaccinated, rather than infected, as children, especially those vaccinated with acellular vaccines. Understanding how vaccine components function in pathogenesis and immunity is critical to the development of improved vaccines. The causative agents of pertussis are Bordetella pertussis and Bordetella parapertussishu. These strictly human-specific pathogens are extremely closely related to Bordetella bronchiseptica, which has a broad host range that includes nearly all mammals. We have been taking a comparative approach, including all three of these Bordetella subspecies to study the roles of virulence gene regulation and of specific virulence factors in pathogenesis. Using B. bronchiseptica allows us to study respiratory infection in the lab in the context of a natural bacterial-host interaction, and the use of chimeric B. bronchiseptica and B. pertussis strains that express heterologous virulence factors has allowed us to demonstrate that several virulence factors, including Filamentous hemagglutinin (FHA), are functionally interchangeable between these subspecies. FHA is a large surface-associated and secreted protein and one of the primary components of pertussis vaccines. We have shown that FHA is required for colonization of the lower respiratory tract (specifically the trachea) and that it allows Bordetella to suppress the inflammatory response of its hosts. FHA is also one of the prototypical members of the Two Partner Secretion (TPS) pathway family. Our previous studies showed that the topology of FHA on the bacterial surface was the opposite of what had been assumed and led to the development of a new model for TPS. Our studies also demonstrated the importance of studying secretion and function simultaneously as results from secretion experiments revealed insight into function and vice versa. We propose experiments to determine how FHA modulates inflammation in the respiratory tract, to identify host cell receptors for FHA, and to identify specific regions and amino acids within FHA that are important for receptor binding. In addition to revealing mechanisms of FHA function, our results may identify novel pathways by which inflammation is controlled in general. We will also determine how the C-terminus of the FHA precursor, FhaB, controls maturation and release of FHA from the bacterial surface. Our results will provide insight into the TPS mechanism, and may set a new paradigm for how proteins are folded on cell surfaces.
Pertussis (also known as whooping cough) remains a public health problem and cases are on the rise in developed countries due, apparently, to waning immunity in adolescents and adults who were vaccinated, rather than infected, as children. We will conduct experiments to determine how one of the proteins included in the acellular pertussis vaccine, Filamentous Hemagglutinin (FHA), functions during infection to influence the inflammatory response. We will also investigate the complex mechanism by which the FHA protein is exported to the bacterial cell surface. Understanding FHA secretion and function is critical for the development of more efficacious pertussis vaccines.
|Hoffman, Casandra; Eby, Joshua; Gray, Mary et al. (2017) Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro. Mol Microbiol 103:214-228
|Bone, M Ashley; Wilk, Aaron J; Perault, Andrew I et al. (2017) Bordetella PlrSR regulatory system controls BvgAS activity and virulence in the lower respiratory tract. Proc Natl Acad Sci U S A 114:E1519-E1527
|Carbonetti, Nicholas H; Wirsing von König, Carl Heinz; Lan, Ruiting et al. (2016) Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development. Clin Vaccine Immunol 23:842-850
|Scheller, Erich V; Cotter, Peggy A (2015) Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential. Pathog Dis 73:ftv079
|Melvin, Jeffrey A; Scheller, Erich V; Noël, Christopher R et al. (2015) New Insight into Filamentous Hemagglutinin Secretion Reveals a Role for Full-Length FhaB in Bordetella Virulence. MBio 6:
|Scheller, Erich V; Melvin, Jeffrey A; Sheets, Amanda J et al. (2015) Cooperative roles for fimbria and filamentous hemagglutinin in Bordetella adherence and immune modulation. MBio 6:e00500-15
|Melvin, Jeffrey A; Scheller, Erich V; Miller, Jeff F et al. (2014) Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol 12:274-88
|Hewlett, Erik L; Burns, Drusilla L; Cotter, Peggy A et al. (2014) Pertussis pathogenesis--what we know and what we don't know. J Infect Dis 209:982-5
|Mason, Eliza; Henderson, Michael W; Scheller, Erich V et al. (2013) Evidence for phenotypic bistability resulting from transcriptional interference of bvgAS in Bordetella bronchiseptica. Mol Microbiol 90:716-33
|Byrd, Matthew S; Mason, Eliza; Henderson, Michael W et al. (2013) An improved recombination-based in vivo expression technology-like reporter system reveals differential cyaA gene activation in Bordetella species. Infect Immun 81:1295-305
Showing the most recent 10 out of 11 publications